Diginex Adds End-to-End Risk-to-Remedy for $3.8B Supply Chain Compliance Market
DGNX•Diginex has integrated Risk-to-Remedy into LUMEN and APPRISE, combining worker-level evidence and prioritised remediation with regulator-ready reporting. With the supply chain due diligence market at $3.8B in 2025 and projected to reach $9.6B by 2034, regulations like the CSDDD and German Supply Chain Act are boosting corporate compliance spending.
1. Integration of Risk-to-Remedy
Diginex integrated the Risk-to-Remedy solution into its LUMEN and APPRISE platforms, providing a unified framework that incorporates direct worker engagement, prioritised remediation workflows and regulator-ready reporting to enhance supply chain transparency.
2. Market Size and Regulatory Imperatives
The human rights and supply chain due diligence market reached $3.8 billion in 2025 and is forecast to expand to $9.6 billion by 2034, driven by enforceable frameworks such as the EU’s CSDDD and Germany’s Supply Chain Due Diligence Act that mandate defensible evidence of labour practices.
3. Upcoming Feature Enhancements
Upcoming updates will enable clients to automate assessments and audits, organize supporting evidence more effectively, monitor non-compliance with dashboard controls, and maintain comprehensive records of corrective actions, positioning Diginex as a provider of scalable end-to-end compliance tools.
